An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer.
Morrow, Phuong Khanh; Murthy, Rashmi K.; Ensor, Joe D.; Gordon, Gilad S.; Margolin, Kim A.; Elias, Anthony D.; Urba, Walter J.; Weng, David E.; Rugo, Hope S.; Hortobagyi, Gabriel N.; Cancer (0008543X), 2012, vol. 118, issue 17, p 4098, ISSN 0008543x. ISBN 10970142.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef